Search results
Cyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%,...
Cyclerion Therapeutics Third Quarter 2022 Earnings: US$0.24 loss per share (vs US$0.26 loss in 3Q...
Simply Wall St. via Yahoo Finance· 2 years agoCyclerion Therapeutics (NASDAQ:CYCN) Third Quarter 2022 ResultsKey Financial Results Net loss:...
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company...
Benzinga via Yahoo Finance· 1 year agoCyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat...
Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction
Benzinga via Yahoo Finance· 2 years agoCyclerion Therapeutics Inc (NASDAQ: CYCN) is reprioritizing development programs and focusing...
Cyclerion Neurology Candidate Shows Encouraging Action In Preclinical Studies
Benzinga via Yahoo Finance· 2 years agoCyclerion Therapeutics Inc's (NASDAQ: CYCN) preclinical studies demonstrated its lead soluble...
Is Cyclerion Therapeutics (NASDAQ:CYCN) In A Good Position To Invest In Growth?
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Cyclerion Therapeutics' Market Cap Drops To US$5.0m Leaving Insiders With Losses
Simply Wall St. via Yahoo Finance· 6 months agoInsiders who bought US$1.95m worth of Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN) stock at an...
12 Best Biotech Penny Stocks to Invest In
Insider Monkey via Yahoo Finance· 2 months agoIn this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5...